XBiotech's Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease; Bermekimab Therapy Rapidly and Significantly Reduces Disease

  • Alice Gottlieb

Press/Media

Period12 Dec 2018

Media coverage

2

Media coverage

  • TitleXBiotech's Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease; Bermekimab Therapy Rapidly and Significantly Reduces Disease
    Media name/outletPrimeNewswire (Top News)
    Country/TerritoryUnited States
    Date12/12/18
    PersonsAlice Gottlieb
  • TitleXBiotech's Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease; Bermekimab Therapy Rapidly and Significantly Reduces Disease
    Media name/outletPrimeNewswire (XML)
    Country/TerritoryUnited States
    Date12/12/18
    PersonsAlice Gottlieb